Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Non-Customized |
Still deciding? Get samples of US$ 100/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Factory supply CAS: 151096-09-2 Moxifloxacin Powder
Product name
|
Moxifloxacin |
CAS NO.
|
151096-09-2 |
MF
|
C21H24FN3O4 |
Standard
|
Medical standard
|
Appearance
|
White powder
|
Assay
|
99%
|
Shelf life
|
2 years
|
Storage
|
should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
|
Test
|
Specification
|
Results
|
Appearance
|
White crystalline Powder
|
Conforms
|
Identification
|
HPLC conform
|
Conforms
|
Loss on drying
|
≤0.5%
|
0.0024
|
Melting Point
|
215-225ºC
|
223ºC
|
Residue on ignition
|
≤0.2%
|
0.0006
|
Iron
|
≤0.005%
|
0.000016
|
Heavy metals
|
≤0.001%
|
0.000006
|
Related substance
|
Total:≤1.0%
|
0.0037
|
|
Individual:≤0.5%
|
0.0017
|
The largest unknown impurities
|
≤ 0.15%
|
Conforms
|
Total impurities(HPLC)
|
≤ 1.0%
|
Conforms
|
Assay
|
Between 98.0% to 101.0%
|
0.9851
|
Function & Application
Moxifloxacin is a synthetic quinolone antibacterial drug and is a relatively new synthetic antibacterial drug. It has the advantages of strong antibacterial activity, wide antibacterial spectrum, low resistance to drug resistance, effective antibiotic resistance, long half-life, and less adverse reactions.
Moxifloxacin treats adults with upper respiratory tract and lower respiratory tract infections. Such as acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, and skin and soft tissue infections.